While a role for defective polymerase proofreading in human cancer has long been postulated, this has only recently been confirmed, with the demonstration that germline mutations in the exonuclease domains of POLE and POLD1 (which encode the principal subunits of Pols ε and δ respectively) predispose to cancer.1 The gene discussed is POLE; the disease is cancer.